benzyl isothiocyanate has been researched along with verlukast in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyagawa, M; Munemasa, S; Murata, Y; Nakamura, T; Nakamura, Y; Seto, M; Xu, W; Yang, Q; Zhu, B | 1 |
1 other study(ies) available for benzyl isothiocyanate and verlukast
| Article | Year |
|---|---|
A multidrug resistance-associated protein inhibitor is a potential enhancer of the benzyl isothiocyanate-induced apoptosis induction in human colorectal cancer cells.
Topics: Apoptosis; Colorectal Neoplasms; HCT116 Cells; Humans; Isothiocyanates; Multidrug Resistance-Associated Proteins; Propionates; Quinolines | 2021 |